Back
Perspective Therapeutics Stock Price Chart
Invest in the Next Big AI Disruptor Today
Learn More
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.54
Seasonality Move:
-10.27%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.69 | Sell |
| 20-day SMA: | 14.08 | Sell |
| 50-day SMA: | 13.75 | Sell |
| 200-day SMA: | 11.57 | Buy |
| 8-day EMA: | 12.79 | Sell |
| 20-day EMA: | 13.53 | Sell |
| 50-day EMA: | 13.63 | Sell |
| 200-day EMA: | 11.56 | Buy |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 39.77 | Sell |
| Chaikin Money Flow: | -64266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.01 - 15.73) | Sell |
| Bollinger Bands (100): | (11.41 - 15.47) | Sell |
Perspective Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 12.57 while CATX 8-day simple moving average is 12.69, which is a Sell signal.
- The stock price of CATX is 12.57 while Perspective Therapeutics 20-day SMA is 14.08, which makes it a Sell.
- Perspective Therapeutics 50-day simple moving average is 13.75 while CATX share price is 12.57, making it a Sell technically.
- CATX stock price is 12.57 and Perspective Therapeutics 200-day simple moving average is 11.57, creating a Buy signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Sell
The current Perspective Therapeutics [CATX] share price is $12.57. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
847.57M
Price in USD:
12.57
Share Volume:
484.14K
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.20
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 12.57 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 12.57 while CATX 8-day exponential moving average is 12.79, which is a Sell signal.
- The stock price of CATX is 12.57 while Perspective Therapeutics 20-day EMA is 13.53, which makes it a Sell.
- Perspective Therapeutics 50-day exponential moving average is 13.63 while CATX share price is 12.57, making it a Sell technically.
- CATX stock price is 12.57 and Perspective Therapeutics 200-day simple moving average is 11.56, creating a Buy signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is -0.52, suggesting Perspective Therapeutics is a Sell
- Perspective Therapeutics Relative Strength Index (RSI) is 39.77, which suggest Perspective Therapeutics is oversold
- The Bollinger Bands (25) for Perspective Therapeutics is (13.01 - 15.73), which suggest Perspective Therapeutics is a Sell
- The Bollinger Bands (100) for Perspective Therapeutics is (11.41 - 15.47), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.